An Invitation to a “Science for Lunch” Hosted by Caidya in Conjunction with Medicon Village
Join Caidya for a lunchtime discussion on how clinical data quality, Risk-Based Quality Management (RBQM), and proactive oversight can strengthen clinical development and support investor confidence.
Reliable clinical data is more than a regulatory requirement. It can influence how investors assess risk, credibility, and the potential value of a development program. Discover how a proactive approach to trial quality can reduce uncertainty and support more informed decisions.
The Conversation
Sarah Gill, Executive Director, Clinical Monitoring at Caidya, will share practical perspectives on the strategic value of clinical trial quality and reliable data.
Topics will include:
- How data quality influences investor confidence and perceptions of risk.
- How proactive oversight can identify risks early and support development milestones.
- How RBQM, analytics, and integrated data oversight can strengthen strategic decision-making.
Designed around knowledge sharing and practical insights, this session will encourage open discussion and the exchange of experiences—not product marketing or sales.
Schedule of the Day
- 11:45am – Welcome, lunch, and networking
- 12:00pm – Presentation and discussion
- 12:40pm – Q&A
- 1:00pm – Coffee and networking
Reserve Your Place
Join us for an insightful discussion on how robust clinical data and proactive quality management can support stronger development strategies and investor confidence.
Caidya will cover all costs associated with the event.
We look forward to welcoming you!
Hosted by Caidya
Sarah Gill
Executive Director, Clinical Monitoring
Mario Bautista
Head of Business Development
Nikola Strumberger
Senior Vice President, Scientific Solutions
About Caidya
Caidya is a global, therapeutically focused drug development partner helping biotech and biopharma sponsors make smarter decisions, move faster, and advance together. Our connected teams combine scientific insight, operational expertise, and local knowledge across critical markets to generate actionable evidence and keep complex development programs moving forward.